首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >FORMULATION OF TETRANDRINE BEADS USING IONIC GELATION METHOD CA-PECTINATE COATED PH-SENSITIVE POLYMERS AS COLON-TARGETED DOSAGE FORM
【24h】

FORMULATION OF TETRANDRINE BEADS USING IONIC GELATION METHOD CA-PECTINATE COATED PH-SENSITIVE POLYMERS AS COLON-TARGETED DOSAGE FORM

机译:离子胶凝法将戊二酸乙二胺酯包被的PH敏感聚合物以结肠定剂量形式制备

获取原文
           

摘要

Objectives Pectin, a natural polysaccharide, can be used as colon targeted drug delivery systems. Ionotropic gelation of pectin in the presence of certain divalent cations, such as calcium ions, protects drugs by producing insoluble hydrogels that can be used as a colon-targeted drug delivery carrier. In this study, calcium pectinate beads containing tetrandrine were made and were evaluated for in-vitro drug release and in-vivo study. Methods: Calcium pectinate beads were prepared by ionic gelation method with varied calcium chloride concentration (5%, 10%, and 15%). The best formula was coated with pH sensitive polymers, i.e. Eudragit L100-55, Eudragit L100, HPMCP (Hydroxypropylmethyl Cellulose Phthalate) HP-55 or CAP (Cellulose Acetate Phthalate). Results: Characterization results showed that the beads produced were quite spherical and have yellow-brownish color. After the coating process, beads were used in in-vitro drug release and targeted test. From in-vitro release study, beads coated with Eudragit L100 10% has shown good colon targeted dosage form with percent cumulative release 57.87%. This result also confirmed with the in-vivo test. Beads which were coated by Eudragit L100 10% could be found in the rat intestine. Conclusion: Formula 1 (5% calcium chloride concentration) was chosen as the best beads characterization. Formula 1C (5% beads coated with 10% Eudragit L100) showed an optimal protection from gastric acid in the in-vitro release study and able to deliver the beads to the intestine in the in-vivo targeted test.
机译:目的果胶是一种天然多糖,可用作结肠靶向药物递送系统。果胶在某些二价阳离子(例如钙离子)存在下的离子胶凝作用通过产生不溶性水凝胶来保护药物,所述不溶性水凝胶可用作结肠靶向药物的输送载体。在这项研究中,制备了含有粉防己碱的果胶钙珠,并进行了体外药物释放和体内研究的评估。方法:采用离子凝胶法制备果胶酸钙珠,氯化钙浓度分别为(5%,10%和15%)。最好的配方是用对pH敏感的聚合物(即Eudragit L100-55,Eudragit L100,HPMCP(羟丙基甲基纤维素邻苯二甲酸酯)HP-55或CAP(醋酸纤维素邻苯二甲酸酯)涂覆的。结果:表征结果表明,所产生的珠是相当球形的并且具有黄棕色的颜色。包衣过程后,将珠用于体外药物释放和靶向测试。根据体外释放研究,包被10%Eudragit L100的珠子显示出良好的结肠靶向剂型,累积释放百分比为57.87%。体内试验也证实了该结果。在大鼠肠中可以发现被10%Eudragit L100包被的珠子。结论:公式1(氯化钙浓度为5%)被选为最佳珠子表征。配方1C(含10%Eudragit L100的5%珠子)在体外释放研究中显示出对胃酸的最佳保护作用,并且能够在体内靶向测试中将珠子递送至肠道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号